Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flow from Operating Activities
Net earnings	$ 11.2	$ 17.7
Depreciation and amortization	21.4	22.2
Share-based compensation expense	5.5	5.3
Loss on sale of assets	0.3	0.2
Deferred compensation payments	(0.5)	(0.2)
Deferred income taxes	(0.1)	0.0
Other, net	1.7	1.0
Change in operating assets and liabilities	(118.5)	(128.7)
Net cash used by operating activities	(79.0)	(82.5)
Cash Flow from Investing Activities
Capital expenditures	(9.4)	(10.2)
Acquisition of Billie, net of cash acquired	308.8	0.0
Proceeds from sale of Infant and Pet Care business	5.0	7.5
Acquisition of Cremo	0.0	(0.3)
Collection of deferred purchase price on accounts receivable sold	0.8	1.5
Payments for other investing activities	(0.3)	(0.8)
Net Cash Provided by (Used in) Investing Activities, Total	(312.7)	(2.3)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	198.0	0.0
Net increase in debt with original maturities of 90 days or less	1.4	2.5
Dividends to common shareholders	(8.5)	0.0
Repurchase of shares	(24.5)	(9.2)
Net financing (outflow) inflow from the Accounts Receivable Facility	(1.6)	4.2
Employee shares withheld for taxes	(9.7)	(3.0)
Proceeds (payments) for other financing activities	0.4	0.0
Net cash from (used by) financing activities	155.5	(5.5)
Effect of exchange rate changes on cash	(3.2)	6.4
Net decrease in cash and cash equivalents	(239.4)	(83.9)
Cash and cash equivalents, beginning of period	479.2	364.7
Cash and cash equivalents, end of period	$ 239.8	$ 280.8